Quick Answer: GLP-1 receptor agonists produce modest reductions in total cholesterol, LDL cholesterol, and triglycerides, though they are not primarily indicated for cholesterol management
Today, in addition to treating diabetes and obesity, these medications are showing promise in the treatment of countless other health problems, including sleep apnea, kidney disease, inflammation and heart disease
L., Silva-Almeida, C., Pestana, F
Overview of the Phase 2 NEJM Trial Design and Participants Weight Loss Results at 48 Weeks: Key Percentage Findings Safety Profile and Side Effects Reported in the Trial How These Results Compare to Other Weight Loss Medicines What the Findings Mean for Future Treatment in the UK Scientific References Frequently Asked Questions What Is Retatrutide and How Does It Work
With many finding keeping weight off through diet and exercise challenging, excitement is growing around drugs that have been found to help people lose large amounts of weight by mimicking hormones that help people feel full after consuming food